BG
Bunge Global SA (BG)·Q3 2025 Earnings Summary
Executive Summary
- Adjusted EPS beat while revenue and EBITDA came in below consensus; BG delivered $2.27 adjusted EPS vs $1.97 consensus, on net sales of $22.16B vs $23.19B consensus and EBITDA of ~$0.73B vs ~$0.84B consensus; management maintained FY25 adj. EPS of $7.30–$7.60 for the combined company . S&P Global estimates marked with asterisks below.*
- Strong execution and footprint from Viterra drove step-up in Soybean and Softseed Processing & Refining; Grain Merchandising was softer in Q3 with better seasonal setup into Q4 per management .
- Non-GAAP adjustments were material: mark-to-market timing (-$0.87/sh) and notable items (-$0.54/sh) weighed on GAAP EPS ($0.86), underscoring importance of adjusted views .
- Capital allocation: $545M repurchased in Q3; net debt now modestly above RMI (
$0.9B), leverage 2.2x adj net debt/adj EBITDA; ample liquidity ($9.7B committed facilities) . - Near-term catalysts: synergy capture ramps in 2026 with larger step by 2027; Q4 mix shifts (softer soy/softseed, stronger grain); biofuel policy clarity expected late 2025/early 2026 with soybean oil tailwinds thereafter .
What Went Well and What Went Wrong
- What Went Well
- Soy and softseed strength on higher margins and added capacity; Soybean adj. Segment EBIT rose to $478M from $286M; Softseed to $275M from $133M, aided by Argentina, Europe and Global Oils execution .
- Integration benefits beginning: “unlocking efficiencies—optimizing our footprint, coordinating larger flows, and running at higher utilization” (CEO) .
- Shareholder returns and balance sheet: $545M buybacks; upgraded credit profile with strong committed liquidity; adjusted ROIC 8.5% TTM (10% pro forma adjustments) and WACC lowered to 6% (adj 6.7%) (CFO) .
- What Went Wrong
- Revenue/EBITDA below consensus; EBITDA ~$0.73B vs ~$0.84B est; revenue $22.16B vs $23.19B est; Grain Merchandising EBIT weak ($21M), partially offset by seasonality expected to improve in Q4 .*
- Non-GAAP noise significant: mark-to-market timing difference of $0.87/sh and notable items $0.54/sh depressed GAAP EPS; reliance on adjusted metrics to assess core performance .
- Corporate/Other elevated on integration costs; Q3 Corporate & Other EBIT -$268M (adj. -$167M) vs -$130M (adj. -$68M) prior year; integration costs of $101M in Q3 .
Financial Results
Overall results (oldest → newest):
Q3 2025 Actual vs S&P Global Consensus (EPS/revenue/EBITDA; asterisks = S&P Global):
Values retrieved from S&P Global.*
Segment performance (Adjusted Segment EBIT, $MM; oldest → newest):
Operating KPIs (volumes; Q3 2024 vs Q3 2025):
Non-GAAP drivers and adjustments:
- Mark-to-market timing differences impacted Q3: +$246M at total EBIT; +$0.87/sh at EPS level; notable items -$108M EBIT; -$0.54/sh .
- Corporate integration costs mainly in SG&A: $101M in Q3; YTD $168M SG&A, $20M interest .
Guidance Changes
Note: Q2 guidance reflected Bunge standalone; October 15 recast updated for the combined company and was maintained on Q3 release .
Earnings Call Themes & Trends
Management Commentary
- “We’re beginning to realize the benefits of our expanded global platform… unlocking efficiencies—optimizing our footprint, coordinating larger flows, and running at higher utilization” — CEO Greg Heckman .
- “Adjusted EPS was $2.27… Adjusted segment EBIT was $924 million… higher results in soybean and softseed processing and refining, with Viterra assets contributing” — CFO John (prepared remarks) .
- “We expect a softer Q4 in both Soybean and Softseed Processing & Refining… and a meaningful improvement in Grain Merchandising & Milling with harvest timing” — CFO .
- “Synergies: little in 2025, meaningful in 2026, larger step in 2027; we expect to be at or ahead of plan” — CFO/CEO .
- “Net debt exceeded RMI by ~ $900 million… adjusted leverage 2.2x; committed credit facilities ~$9.7 billion” — CFO .
- “Biofuel policy: final proposal likely end-2025/early-2026; improvement in soybean oil side of crush margin early 2026” — CEO .
Q&A Highlights
- Biofuel policy timing and SBO margins: Management expects clarity late 2025/early 2026 with improvement in SBO-driven crush margins from early 2026; half-RIN for foreign feedstocks uncertain operationally but supportive of domestic SBO .
- Viterra contribution and synergy capture: Early contributions in soy/softseed; merchandising timing to improve in Q4; synergy capture accelerates in 2026, larger in 2027; aim to exceed proxy targets .
- Segment outlook into Q4: Softer soy/softseed; better grain and slightly less negative Corporate & Other; confirms Q4 down vs Q3, consistent with 2H guide .
- Capital returns: ~$2B buybacks since Viterra announcement; ~$255M left on Viterra program with intent to continue buybacks beyond completion .
- Regional flows: Big Australia crop (wheat, barley, rapeseed) supportive; Argentina balance reduces historical volatility risk for BG; potential China program shifts in 2026 .
Estimates Context
- Q3 2025 results vs S&P Global consensus: EPS beat ($2.27 vs $1.97), revenue miss ($22.16B vs $23.19B), EBITDA miss (~$0.73B vs ~$0.84B). Management commentary suggests execution and margin capture in processing outweighed softer merchandising and policy-driven customer “spot” behavior, while integration costs and mark-to-market timing added noise .*
- FY25 outlook: Maintained $7.30–$7.60 adj. EPS for the combined company, implying Q4 softness offset by seasonal grain strength and execution; estimate revisions may drift higher for soy/softseed segments, but Q4 caution and 2026 policy timing could cap near-term EPS raises .*
Values retrieved from S&P Global.*
Key Takeaways for Investors
- Core processing momentum: Strong soy/softseed adjusted EBIT with new scale in Argentina/Europe; execution is driving above-peer performance in complex markets .
- Quality of beat: EPS beat despite revenue/EBITDA miss, aided by mix and execution; non-GAAP noise (mark-to-market and integration) remains elevated—focus on adjusted metrics .
- 4Q mix shift: Expect softer processing/refining but better grain merchandising with global harvests; near-term set-up is balanced against maintained FY guide .
- 2026–2027 upside: Synergies accelerate in 2026 with a larger step in 2027; biofuel policy clarity early 2026 likely supports SBO-driven crush margins; setup favors medium-term EPS power .
- Capital returns building: Mega projects wind down by 2026, freeing cash for buybacks; leverage manageable with robust liquidity .
- Watch list: Biofuel policy finalization timing, China purchase patterns in 2026, Argentina operating environment, and grain merchandising normalization into Q4/Q1 .
- Stock narrative: Near-term “prove-out” of Q4 mix and synergy traction; medium-term thesis anchored on combined platform scale, synergy capture, and policy tailwinds—potential catalysts at Q4 call and Investor Day update on mid-cycle earnings .
Appendix: Additional Data and Disclosures
- Selected cash flow and balance sheet: YTD cash from ops -$503M (working capital), Adjusted FFO $1.18B; cash & equivalents $1.32B at 9/30/25; short-term + long-term debt $15.6B post-merger; inventories $13.31B (RMI $11.51B) .
- Certain gains/(charges) detail: Q3 corporate acquisition/integration costs -$101M EBIT (-$0.50/sh); reportable segments de minimis/notable .
- Share repurchases: $545M in Q3; total since Viterra announcement >$2B; ~$255M remaining on the Viterra-specific program .